
National Research Corporation NRC
€ 17.01
3.73%
Quartalsbericht 2026-Q1
hinzugefügt 06.05.2026
National Research Corporation ROE 2011-2026 | NRC
ROE Jährlich National Research Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 82.92 | 79.22 | 63.26 | 44.15 | 43.9 | 57.93 | 98.52 | 157.45 | 25.48 | 24.78 | 23.73 | 20.69 | 21.58 | - | - | 23.8 | 19.22 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 157.45 | 19.22 | 52.44 |
ROE Vierteljährlich National Research Corporation
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71.68 | 64.23 | 50.8 | 68.51 | 49.0 | 62.61 | 55.54 | 49.5 | 32.29 | 44.54 | 43.05 | 44.18 | 34.85 | 46.47 | 45.94 | 46.41 | 35.93 | 50.82 | 51.2 | 57.77 | 45.17 | 69.85 | 77.43 | 90.36 | 72.08 | 108.72 | 125.68 | 141.49 | 116.57 | 121.19 | 90.94 | 56.53 | 18.24 | 23.95 | 24.85 | 25.11 | 17.86 | 23.44 | 23.21 | 22.39 | 15.74 | 20.93 | 19.97 | 20.71 | 16.02 | 21.33 | 20.93 | 22.54 | 16.33 | 22.63 | 24.26 | 26.26 | 20.03 | 24.79 | 22.68 | 21.96 | 15.18 | 4.76 | 4.19 | 6.22 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 141.49 | 4.19 | 44.46 |
ROE anderer Aktien in der Diagnostik & Forschung
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | ||
|
Fulgent Genetics
FLGT
|
-5.44 | $ 19.5 | 7.5 % | $ 600 M | ||
|
Celcuity
CELC
|
-176.06 | $ 92.47 | 3.96 % | $ 4.32 B | ||
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-227.33 | $ 5.76 | 11.41 % | $ 7.66 M | ||
|
Castle Biosciences
CSTL
|
-5.13 | $ 21.6 | 5.93 % | $ 626 M | ||
|
Aspira Women's Health
AWH
|
0.18 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
89.3 | - | -61.36 % | $ 2.46 M | ||
|
Guardant Health
GH
|
419.21 | $ 133.06 | 4.75 % | $ 16.7 B | ||
|
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M | ||
|
ICON Public Limited Company
ICLR
|
2.49 | $ 152.8 | 6.18 % | $ 12 B | ||
|
CareDx, Inc
CDNA
|
-7.05 | $ 23.12 | 3.63 % | $ 1.23 B | ||
|
Illumina
ILMN
|
31.22 | $ 168.06 | -1.68 % | $ 26 B | ||
|
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
120.45 | - | - | $ 9.42 M | ||
|
Interpace Biosciences
IDXG
|
109.89 | $ 1.79 | 2.29 % | $ 7.92 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-656.53 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | ||
|
Mettler-Toledo International
MTD
|
-3677.41 | - | - | $ 24.3 B | ||
|
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
21.43 | - | - | $ 6.94 B | ||
|
NeoGenomics
NEO
|
-12.91 | $ 11.31 | 11.54 % | $ 1.45 B | ||
|
Charles River Laboratories International
CRL
|
-4.56 | $ 185.79 | 3.29 % | $ 9.21 B | ||
|
Natera
NTRA
|
-12.16 | $ 222.1 | 4.84 % | $ 30.4 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
98.27 | $ 458.69 | 1.75 % | $ 13.2 B | ||
|
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
-99.46 | $ 4.69 | 6.59 % | $ 434 M | ||
|
Personalis
PSNL
|
-31.12 | $ 12.1 | 12.24 % | $ 1.08 B | ||
|
Koninklijke Philips N.V.
PHG
|
8.16 | $ 25.99 | 2.52 % | $ 24.6 B | ||
|
Senseonics Holdings
SENS
|
-113.19 | $ 7.01 | 4.32 % | $ 293 M | ||
|
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
4.64 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-121.14 | - | - | $ 4.94 M | ||
|
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 260.97 | 0.79 % | $ 21.7 B | ||
|
Twist Bioscience Corporation
TWST
|
-16.42 | - | - | $ 4.42 B | ||
|
Thermo Fisher Scientific
TMO
|
12.55 | $ 482.03 | 1.7 % | $ 182 B | ||
|
Trinity Biotech plc
TRIB
|
88.73 | $ 0.68 | -2.4 % | $ 244 M | ||
|
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
-52.72 | $ 9.12 | 3.52 % | $ 1.98 B | ||
|
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 196.12 | 1.27 % | $ 21.8 B | ||
|
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | ||
|
Waters Corporation
WAT
|
25.09 | $ 376.47 | -0.87 % | $ 22.4 B |